pioglitazone has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morrow, JP | 1 |
Katchman, A | 1 |
Son, NH | 1 |
Trent, CM | 1 |
Khan, R | 1 |
Shiomi, T | 1 |
Huang, H | 1 |
Amin, V | 1 |
Lader, JM | 1 |
Vasquez, C | 1 |
Morley, GE | 1 |
D'Armiento, J | 1 |
Homma, S | 1 |
Goldberg, IJ | 1 |
Marx, SO | 1 |
1 other study available for pioglitazone and Atrioventricular Nodal Re-Entrant Tachycardia
Article | Year |
---|---|
Mice with cardiac overexpression of peroxisome proliferator-activated receptor γ have impaired repolarization and spontaneous fatal ventricular arrhythmias.
Topics: Action Potentials; Animals; Calcium; Connexin 43; Death, Sudden, Cardiac; Disease Models, Animal; El | 2011 |